NCT00538005 2014-01-10Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant MelanomaNational Cancer Institute (NCI)Phase 1/2 Unknown54 enrolled
NCT00811759 2010-10-07Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV MelanomaNational Cancer Institute (NCI)Phase 1/2 Unknown58 enrolled